Product Details
| Product Name: Ipragliflozin | CAS No.: 761423-87-4 |
| Min. Order: 50g | Purity: 99% |
| Supply Ability: 15kg | Release date: 2025/09/22 |
Name Ipragliflozin
Synonyms (1S)-1,5-Anhydro-1-C-[3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl]-D-glucitol
Molecular Structure
Molecular Formula C21H21FO5S
Molecular Weight 404.45
CAS Registry Number 761423-87-4
Company Profile Introduction
Cangzhou Kangrui Pharma Tech Co. Ltd., located in the southeast of Hebei Province, is a scientific and technological innovation company integrating the production, research and development, and sales of pharmaceutical intermediates.
Cangzhou Kangrui Pharma Tech Co. Ltd., has 5 researchers including 2 doctors and 3 masters. The whole team have many years of industry background in chemical synthesis and generic and innovative drug development.
Cangzhou Kangrui Pharma Tech Co. Ltd., has 300m2?R&D center located at Zhi Fang Tou Industrial Park, as well as several cooperative manufacturing.
Cangzhou Kangrui Pharma Tech Co. Ltd., takes the international advanced management mode to operate well-equipped laboratories for synthesis, analysis detection. Cang Zhou Kangrui can provide clients with high quality service based on well-developed research and development system, quality management system and production conditions.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $52.00/25mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-11-10 | |
| $6.00/1kg |
Hebei Fengjia New Material Co., Ltd
|
2024-09-04 | ||
| $0.00/1kg |
Nanjing Fred Technology Co., Ltd
|
2024-01-04 | ||
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 | ||
| $166.00/5g/Bag |
VIP5Y
|
Baoji Guokang Healthchem Co., Ltd.
|
2021-06-04 | |
| $1.00/1KG |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-09 | |
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-08 |
- Since: 2022-08-22
- Address: Building 1, Jinding Field, Yuhe West Road, Yunhe District, Cangzhou City, Hebei Province, China 2-23
INQUIRY

China